Agenda: Recent Advances to Accelerate & Scale Cell & Gene Therapies

6:00 pm Registration & Welcome Reception

6:30 pm Opening Remarks

6:35 pm Panel Discussion & Q&A: Optimizing Next Generation Cell Therapy Starting Materials

  • Dominic Clarke Chief Technical Officer of
    Cell & Gene Therapies, Discovery Life Sciences
  • Knut Niss Chief Technology Officer, Mustang Bio
  • Greg Whitehead Chief Quality Officer, Rubius Therapeutics
  • Sheila Smith Senior Director, Clinical Operations, AllCells

Synopsis

• Discuss how pre-characterized human cellular materials will accelerate cell therapy development
• Address the ever-increasing demand for cellular starting materials and review how to increase specific sample cohorts
• Deep dive into the benefits of comprehensive multi-omic services and how it can streamline and accelerate cell therapy research
• Hear how Discovery Life Sciences can unlock a new cell therapy paradigm and discover how it can provide expertise and guidance to accelerate research at every stage of development

7:15 pm Networking & Drinks

Synopsis

Informal and exclusive opportunity to engage with senior pharma leaders interested in manufacturing and supply chain for cellular therapeutics

8:00 pm End of Discovery Life Sciences Engager